Clinical stage hematology research is a well-known and complex field that can be in trouble due to complex regulatory strategies and complex clinical research designs. However, the need for novel hematological disease therapies still remains urgent. CD BioSciences has extensive experience in designing hematological and clinical strategies, and regulatory activities. In order to help our clients achieve the best success in delivering new medical breakthroughs to the market, we provide pre-clinical and one-stop clinical phase I-IV package development services for our world-wide clients.
Hematology Theraprutic Area
CD BioSciences has collaborated with many sponsors on clinical research projects involving hematological diseases, covering the treatment of multiple therapeutic areas such as hyponatremia, red blood cell storage, and acute / chronic leukemia. Specifically, our clinical services for hematology project including study design, PK/PD analysis and modeling, interim analysis, adaptive clinical trial analysis, and clinical monitoring and management, statistical support. Other services include general consulting, chemical, manufacturing and control (CMC) consulting, and feasibility reports.
We have a road range of experience in the following indicatons
Why Choose CD BioSciences?
We have hired some of the brightest people, who put all their deep expertise into clinical development, giving you confidence that we can successfully complete your research. We implement the latest innovative technologies for research in a variety of hematological indications. Whether you are new to clinical drug development or want to partner with us to achieve your next major breakthrough, you can benefit from our competitive advantages, including:
Explore Our Clinical Services for a Complete Picture by Stage:
CD BioSciences' scientists are dedicated to bringing together years of valuable experience to help our clients shorten the clinical trial journey. For further details, please don't hesitate to contact us.